期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

造血干细胞移植后淋巴细胞增殖性疾病研究进展 被引量：1

Study of Development Post-Transplant Lymphoproliferation Disorder Following Hematopioetic Stem Cell Transplantation
下载PDF
导出
摘要 造血干细胞移植后淋巴细胞增殖性疾病是一种少见、爆发性、病死率极高并发症。研究发现,它经常伴外周血单核细胞EB病毒(EBV)负荷快速增加,其发病通常伴一些高危因素,对于存在高危因素者,通过PCR技术检测EBVDNA可做到对此病的早期诊治,抗CD20+抗体应用提高此病存活率。本文总结造血干细胞移植后淋巴细胞增殖性疾病高危因素、早期诊断和合理治疗最新进展。
作者 唐湘凤 栾佐
机构地区 中国人民解放军海军总医院儿科
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第15期1181-1183,共3页 Journal of Applied Clinical Pediatrics
关键词 造血干细胞移植 淋巴细胞增殖性疾病 EB病毒感染
分类号 R725.5 [医药卫生—儿科]
  • 相关文献

参考文献26

  • 1Orentas R J, Schauer DW Jr, Ellis FW,et al. Monitoring and modulation of Epstein - Barr virus loads in pediatric transplant patients [ J ]. Pediatr Transplant, 2003,7 (4) : 305 - 314. 被引量：1
  • 2Gong JZ, Bayerl MG, Sandhaus LM, et al. Posttranplant lymphoproliferative disorder after umbilical cord blood transplantation in children [J]. Am J Surg Pathol,2006 ,30( 3 ) :328 -336. 被引量：1
  • 3Burney K, Bradley M, Buekley A, et al. Posttransplant lymphoproliferative disorder : A pictorial review [ J ], Australas Radiol, 2006,50 ( 5 ) : 412 -418. 被引量：1
  • 4Loren AW, Porter DL, Stadtmauer EA ,et al. Post - transplant lymphoproliferative disorder : A review [ J ]. Bone Marrow Transplant,2003,31 ( 3 ) : 145 - 155. 被引量：1
  • 5Sundin M,Le- Blanc K, Ringden O,et al. The role of HLA mismatch, splenectomy and recipient Epstein - Barr virus seronegtivity as risk factors in post - transplant lymphoproliferative disorders following hematopoietic stem cell transplantation [ J ]. Haematologica, 2006,91 ( 8 ) : 1059 - 1067. 被引量：1
  • 6Bakker NA, van Imhoff GW, Verschuuren EA,et al. HLA antigens and post renal transplant lymphoproliferative disease: HLA -B matching is critical[J]. Transplantation,2005,80(5) :595 -599. 被引量：1
  • 7Snyder Mj, Stenzel TT, Buckley PJ, et al. Posttransplant lymphoproliferative disorders following nonmyeloablative allogeneic stem cell transplantation [ J ]. Am J Surg Pathol,2004,28 (6) :794 - 800. 被引量：1
  • 8Brunstein CG,Weisdorf DJ,DeFor T,et al. Marked increased risk of Epstein - Barr virus - rela-ted eomplications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation [ J ]. Blood, 2006, 108 ( 8 ) : 2874 - 2880. 被引量：1
  • 9Faye A, Vilmer E. Post - transplantation lymphoproliferative disorders in ehildren: Ineidenee, prognosis, and treatment options [ J ]. Paedlatr Drugs,2005,7( 1 ) :55 -65. 被引量：1
  • 10Greenfield HM, Gharib MI, Turner A J, et al. The impact of monitoring Epstein- Barr virus PCR in pediatric bone marrow transplant patients: Can it successfully predict outcome and guide intervention[ J] ? Pediatr Blood Cancer,2006,47(2) :200-205. 被引量：1

同被引文献36

  • 1肖毅,刘文励.异基因造血干细胞移植后继发淋巴增殖性疾病研究进展[J].临床荟萃,2006,21(1):56-59. 被引量：1
  • 2Paya CV, Fung JJ, Nalesnik MA, et al. Epstein-Ban" virus-induced post transplant lympho- proliferative disorders. ASTS/ASTP EBV- PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation, 1999, 68: 1517- 1525. 被引量：1
  • 3Gustafsson A, Levitsky V, Zou J, et al. Epstein-Barr virus(EBV) load in bone marrow transplant recipients at risk to develop post-transplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood, 2000, 95: 807-814. 被引量：1
  • 4Baker KS, DeFor TE, Burns LJ, et al. New malignancies after blood or marrow stem cell transplantation in children and adults: incidence and risk factors. J Clin Oncol, 2003, 21: 1352-1358. 被引量：1
  • 5Weinstock DM. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. BMT, 2006, 37: 539-546. 被引量：1
  • 6Snyder MJ, Stenzel TY, Buckley PJ, et al. Post-transplant lymphoproliferative disorders following nonmyeloablative allogeneic stem cell transplantation. Am J Surg Pathol, 2004, 28: 794-$00. 被引量：1
  • 7Brunstein CG, Weisdorf D J, De For T, et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyetoablative conditioning prior to unrelated umbilical cord blood transplantation. Blood, 2006, 108: 2874-2880. 被引量：1
  • 8Sundin M, Le-Blanc K, Ringden O, et al. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegtivity as risk factors in post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantation. Hematologic, 2006, 91:1059- 1067. 被引量：1
  • 9Faye A, Vilmer E. Post-transplantation lymphoproliferative disorders in children: Incidence, prognosis, and treatment options. Pediatric Drugs, 2005, 7: 55-65. 被引量：1
  • 10Greenfield HM, Gharib MI, Turner A J, et al. The impact of monitoring Epstein-Barr virus PCR in pediatric bone marrow transplant patients: Can it successfully predict outcome and guide intervention? Pedialric Blood Cancer, 2006, 47: 200-205. 被引量：1

引证文献1

二级引证文献3

实用儿科临床杂志
2007年 第15期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部